Skip to main content
. 2024 Nov 29;10(2):101688. doi: 10.1016/j.adro.2024.101688

Table 5.

Adjusted logistic regression models with stepwise models including demographics in model 1, tumor characteristics in model 2, and dual enrollment in model 3

Model 1 Adjusted for demographics
Model 2 Additional adjustment for tumor characteristics
Model 3 Additional adjustment for dual enrollment
Characteristic OR 95% CI P value* OR 95% CI P value* OR 95% CI P value*
Redlining category <.001* <.001* .0091*
 Low
 Moderate 0.93 0.89, 0.99 .0111 0.96 0.91, 1.02 .1264 0.98 0.93, 1.04 .5042
 High 0.82 0.76, 0.88 <.001 0.85 0.79, 0.91 <.001 0.89 0.82, 0.95 .0022
 Moderate vs high <.001 <.001 .0085
SEER Race/Ethnicity <.001* <.001* <.001*
 NH White
 NH Black 0.66 0.61, 0.72 <.001 0.71 0.66, 0.78 <.001 0.78 0.71, 0.84 <.001
 NH Asian 0.98 0.81, 1.14 .7642 0.98 0.81, 1.12 .7816 1.09 0.92, 1.24 .2296
 Hispanic 0.91 0.79, 1.03 .1931 0.96 0.85, 1.08 .4804 1.09 0.96, 1.25 .2072
 NH Black vs NH Asian <.001 <.001 <.001
SEER-Medicare age group <.001 <.001 <.001
 66-70 y
 71-75 y 1.14 1.08, 1.23 <.001 1.13 1.06, 1.22 <.001 1.13 1.06, 1.21 <.001
 76-80 y 0.82 0.76, 0.87 <.001 0.82 0.76, 0.87 <.001 0.82 0.77, 0.87 <.001
 81-85 y 0.47 0.42, 0.51 <.001 0.48 0.43, 0.53 <.001 0.48 0.43, 0.53 <.001
 86-90 y 0.20 0.18, 0.22 <.001 0.22 0.19, 0.24 <.001 0.22 0.19, 0.24 <.001
 71-75 vs 86-90 y <.001 <.001 <.001
Dual enrollment <.001
 No
 Yes 0.64 0.58, 0.71 <.001

Abbreviations: OR = odds ratio; SEER = Surveillance, Epidemiology, and End Results.

Obtained from generalized linear regression model with cluster bootstrap.

Comparison of nonreferent groups with highest discrepancy between ORs was added as post hoc analysis.

Global P value.

Model also adjusted for comorbidities, stage, breast receptor subtype, census region, and year of diagnosis.